Literature DB >> 3089875

Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily.

M Tosi, C Duponchel, P Bourgarel, M Colomb, T Meo.   

Abstract

Genetic and acquired diseases in man show that the proteolytic activity of the complement component C1 is crucially regulated by C1 inhibitor (C1-INH), a plasma protein whose suspected relatedness to other serine proteinase inhibitors (serpins) contrasts with its atypically large size and high degree of glycosylation. Indeed we have found that the C1-INH polypeptide precursor synthesized in a cell-free system is a 64-kDa protein, hence it exceeds the length of the precursor forms of typical serpins. Seeking more conclusive sequence information and a probe for the structural locus, we isolated C1-INH cDNA clones from a library representing size-enriched human liver mRNA. Nucleotide sequence analysis of a clone covering the carboxyterminal half of C1-INH conclusively documents the relatedness of this protein with the serpins, and reveals 27% amino acid identity with alpha 1-antitrypsin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089875     DOI: 10.1016/0378-1119(86)90230-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

2.  Acute paediatric compartment syndrome of the hand caused by hereditary angiooedema.

Authors:  S S Malik; H Uppal; A Sinha; S S Malik; K Katam; K Srinivasan
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

3.  Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r.

Authors:  A Journet; M Tosi
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

4.  Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.

Authors:  A Reboul; M H Prandini; M G Colomb
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

5.  Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.

Authors:  J Jackson; R B Sim; K Whaley; C Feighery
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

6.  Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements.

Authors:  D Stoppa-Lyonnet; P E Carter; T Meo; M Tosi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Molecular cloning and expression of an intracellular serpin: an elastase inhibitor from horse leucocytes.

Authors:  T Kordula; A Dubin; H Schooltink; A Koj; P C Heinrich; S Rose-John
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

8.  Management of upper airway edema caused by hereditary angioedema.

Authors:  Henriette Farkas
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

9.  Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation.

Authors:  K S Aulak; P A Pemberton; F S Rosen; R W Carrell; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

10.  Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.

Authors:  E Verpy; E Couture-Tosi; E Eldering; M Lopez-Trascasa; P Späth; T Meo; M Tosi
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.